These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28299826)

  • 21. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
    Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of In Silico Methods for Regulatory Toxicological Assessment of Pharmaceutical Impurities.
    Kovarich S; Cappelli CI
    Methods Mol Biol; 2022; 2425():537-560. PubMed ID: 35188646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Consultancy Activity on In Silico Models for Genotoxic Prediction of Pharmaceutical Impurities.
    Pavan M; Kovarich S; Bassan A; Broccardo L; Yang C; Fioravanzo E
    Methods Mol Biol; 2016; 1425():511-29. PubMed ID: 27311479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of "Big Data" to Evaluate Responses to Changes in Regulatory Guidelines: Trends in Genotoxicity Testing Packages for New Pharmaceutical Products.
    Reeve L; Baldrick P; Newell A; Templeton S
    Ther Innov Regul Sci; 2020 Jul; 54(4):764-769. PubMed ID: 32557294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines.
    Doak SH; Manshian B; Jenkins GJ; Singh N
    Mutat Res; 2012 Jun; 745(1-2):104-11. PubMed ID: 21971291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
    Schisler MR; Gollapudi BB; Moore MM
    Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Main issues addressed in the 2014-2015 revisions to the OECD Genetic Toxicology Test Guidelines.
    Thybaud V; Lorge E; Levy DD; van Benthem J; Douglas GR; Marchetti F; Moore MM; Schoeny R
    Environ Mol Mutagen; 2017 Jun; 58(5):284-295. PubMed ID: 28266061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety assessment and global regulatory requirements for genetic toxicity evaluations of medical devices.
    Przygoda RT
    Environ Mol Mutagen; 2017 Jun; 58(5):375-379. PubMed ID: 28573657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
    Dekant W; Melching-Kollmuss S; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.
    White PA; Rasmussen JB
    Environ Mol Mutagen; 1996; 27(4):270-305. PubMed ID: 8665872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing emerging mutagenicity risks: Late stage mutagenic impurity control within the atovaquone second generation synthesis.
    Urquhart MWJ; Bardsley B; Edwards AJ; Giddings A; Griva E; Harvey J; Hermitage S; King F; Leach S; Lesurf C; McKinlay C; Oxley P; Pham TN; Simpson A; Smith E; Stevenson N; Wade C; White A; Wooster N
    Regul Toxicol Pharmacol; 2018 Nov; 99():22-32. PubMed ID: 30118726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotoxicity testing approaches for the safety assessment of substances used in food contact materials prior to their authorization in the European Union.
    Bolognesi C; Castoldi AF; Crebelli R; Barthélémy E; Maurici D; Wölfle D; Volk K; Castle L
    Environ Mol Mutagen; 2017 Jun; 58(5):361-374. PubMed ID: 28556235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: Risk assessment of potentially mutagenic impurities.
    Waechter F; Falcao Oliveira AA; Borges Shimada AL; Bernes Junior E; de Souza Nascimento E
    Regul Toxicol Pharmacol; 2024 Jun; 151():105669. PubMed ID: 38936796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamates and ICH M7 classification: Making use of expert knowledge.
    Hemingway R; Fowkes A; Williams RV
    Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report and summary of the major conclusions from statistics in genotoxicity testing working group from the International Workshop on Genotoxicity Test Procedures (IWGTP), March 1999.
    Lovell DP; Yoshimura I; Hothorn LA; Margolin BH; Soper K
    Environ Mol Mutagen; 2000; 35(3):260-3. PubMed ID: 10737960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Hydroxypyridine-N-oxide (HOPO): Equivocal in the ames assay.
    Dobo KL; Cheung JR; Gunther WC; Kenyon MO
    Environ Mol Mutagen; 2018 May; 59(4):312-321. PubMed ID: 29481708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.